Brief: Farmacosmo Reports Fy2025 Adjusted EBITDA Of Eur 2.3 Mln
Mon 19:25
BRIEF-Farmacosmo Reports Fy2025 Adjusted EBITDA Of Eur 2.3 Mln June 22 (Reuters) - Farmacosmo SpA COSMO.MI:
REPORTS FY2025 PRODUCTION VALUE OF EUR 56.3 MILLION, DOWN 12.4% YOY
REPORTS FY2025 ADJUSTED EBITDA OF EUR 2.3 MILLION, UP 4.7%
REPORTS FY2025 NET LOSS OF EUR 4.6 MILLION
APPROVES FY2025 FINANCIAL STATEMENTS AND ALLOCATES EUR 5.36 MILLION NET LOSS TO RETAINED LOSSES
SIGNS MERGER DEED TO INCORPORATE COCCAR S.R.L. (PHARMASÌ) INTO FARMACOSMO S.P.A.
Source text: ID:nBIA3Rm4jd
Further company coverage: COSMO.MI
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Farmacosmo SpA
See all newsBrief: Farmacosmo Reports Fy2025 Adjusted EBITDA Of Eur 2.3 Mln
Brief: Farmacosmo Sees 2026 EBITDA In Range €1.3-1.7 Mln
Brief: Farmacosmo FY Adj EBITDA EUR 2.6 MLN
Brief: Farmacosmo Board Approves Merger By Incorporation Of Coccar S.R.L.
Brief: Farmacosmo Appoints Fabio Scognamiglio As CFO Replacing Paolo Cimmino